Florida Senator Marco Rubio (R), currently involved in a reelection campaign against Florida Rep. Val Demings (D), is highlighting foresight he shared on social media last year. In a tweet, the Florida lawmaker discussed options to combat the COVID-19 virus, sharing that his predictions “became reality in the time frame I predicted.”
13 months ago, Senator Rubio shared that “we may be only months away from having more options on COVID19,” adding that by the fall “we could have monoclonal antibody drugs that can block the coronavirus,” and “by years end we could have a vaccine.”
To conclude, Rubio noted that “the goal now is to buy us time & to protect our hospital capacity by slowing the spread.”
13 months later, Rubio further noted that “both monoclonal antibody treatments & vaccines became reality in the time frame I predicted.”
I wrote this 13 months ago & both monoclonal antibody treatments & vaccines became reality in the time frame I predicted
Both are widely available now
Neither is a substitute for the other
Get Vaccinated AND if you get really sick,get the antibody treatment EARLY pic.twitter.com/FQnxQwQZlw
— Marco Rubio (@marcorubio) August 19, 2021
Noting that “both are widely available now” and that “neither is a substitute for the other,” Rubio concluded by urging that Americans get Vaccinated, “and if you get really sick, get the antibody treatment EARLY.”
In May of this year, the FDA approved an “emergency use authorization for the investigational monoclonal antibody therapy sotrovimab,” which is used “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients.”
Patrizia Cavazzoni, M.D., the Director of the FDA’s Center for Drug Evaluation and Research, commented on the authorization, expressing that the authorization is “providing another option to help keep high-risk patients with COVID-19 out of the hospital.”
Cavazzoni added that “it is important to expand the arsenal of monoclonal antibody therapies that are expected to retain activity against the circulating variants of COVID-19 in the United States.”
